Hugler Chewable Tablets 5 mg (Montelukast Sodium)

Adult dose

Adults and adolescents aged 15 years and older should take 10 mg of montelukast orally once a day. The 10 mg orally disintegrating film should be placed on the tongue and dissolved without water once daily. This medication should be taken once daily; asthma patients should take it in the evening.

Child dose

Children aged 6 to 14 years should take 5 mg of montelukast once daily, chew or place on the tongue to disintegrate and swallow without water. Children aged 4 to 5 years should take 4 mg of montelukast once daily, chew or place on the tongue.

This medication contains aspartame, an artificial sweetener, and should not be used by patients with phenylketonuria due to problems with metabolizing phenylalanine. The daily intake of aspartame in this medication should be minimized to not exceed the WHO recommended limit, with a maximum dosage established for adults. Individuals allergic to this medication or its ingredients should not take it, and patients with lactose intolerance or certain genetic disorders should also refrain from use. This medication is not intended for use during acute asthma attacks; hence, other emergency medications should be used during acute symptoms, and an emergency inhaler should always be carried. During treatment with this medication, inhaled corticosteroids should not be abruptly discontinued or substituted, and should be adjusted gradually according to a physician’s guidance. Rarely, neuropsychiatric symptoms or allergic reactions may occur during treatment with this medication, so patients should consult medical personnel immediately if any abnormal symptoms arise. Patients with aspirin hypersensitivity should avoid taking aspirin or non-steroidal anti-inflammatory drugs while using this medication, as it does not treat bronchoconstriction caused by these drugs. This medication can be used by a wide range of age groups from children to the elderly; however, it is not recommended for children under 6 months of age as safety and efficacy have not been established. In case of overdose, there is no specific antidote, therefore symptomatic treatment and clinical monitoring should be conducted, along with supportive care if necessary. This medication is sensitive to light, thus it must be opened just before taking, and should be taken immediately after opening, while stored in a place out of reach of children. If asthma symptoms worsen or if the use of emergency inhalers increases during treatment, patients should consult a physician and should not change the dosage of other asthma medications without medical supervision.

Serious side effects

Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, anaphylaxis, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin adverse reaction, toxic epidermal necrolysis, Stevens-Johnson syndrome, shortness of breath or difficulty breathing, asthma attack, respiratory distress accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy.

Mild side effects

• Weakness/fatigue
• fever
• abdominal pain
• dyspepsia
• infectious gastroenteritis
• toothache
• dizziness
• headache
• nasal congestion
• cough

This medication is sensitive to moisture and light, and should be stored at room temperature between 1°C and 30°C. Additionally, it is important to store it in a sealed container to prevent air exposure.

Appearance

Pink chewable tablet, round, with a biconvex shape on both sides.

Package unit

28 tablets (7 tablets/PTP X 4), 30 tablets (10 tablets/PTP X 3)